Stevanato Group S.p.A. (STVN)
NYSE: STVN · Real-Time Price · USD
22.48
-0.18 (-0.79%)
Nov 14, 2025, 10:58 AM EST - Market open

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212018 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2018 - 2020
EMEA Revenue
692.77M667.83M
Log In
Log In
Log In
Upgrade
APAC Revenue
101.03M96.24M
Log In
Log In
Log In
Upgrade
North America Revenue
321.83M308.95M
Log In
Log In
Log In
Upgrade
South America Revenue
29.47M31.02M
Log In
Log In
Log In
Upgrade

Revenue

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212018 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2018 - 2020
Biopharmaceutical and Diagnostic Solutions Revenue
976.82M933.74M
Log In
Log In
Log In
Upgrade
Engineering Revenue
168.28M170.29M
Log In
Log In
Log In
Upgrade

Gross Profit

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212018 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2018 - 2020
Biopharmaceutical and Diagnostic Solutions Gross Profit
298.47M268.78M
Log In
Log In
Log In
Upgrade
Engineering Gross Profit
47.14M56.17M
Log In
Log In
Log In
Upgrade
Eliminations from Gross Profit
-24.54M-22.63M
Log In
Log In
Log In
Upgrade

EBIT

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212018 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2018 - 2020
Biopharmaceutical and Diagnostic Solutions Operating Profit
193.51M165.64M
Log In
Log In
Log In
Upgrade
Engineering Operating Profit
28.95M33.10M
Log In
Log In
Log In
Upgrade
Eliminations from Operating Profit
-38.58M-37.59M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 20212018 - 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 2018 - 2020
Backlog
853.00M
Log In
Log In
Log In
Upgrade
Updated Nov 6, 2025. Data Source: Fiscal.ai.